Acacia Recalls 217K IV Devices Over Faulty Component

Law360, New York (February 10, 2010, 2:17 PM EST) -- Acacia Inc. has recalled 217,000 infusion therapy IV systems because of a defect in a component manufactured by Becton Dickinson & Co. that can cause air embolism, blood leakage and even death.

Brea, Calif.-based Acacia announced the voluntary recall for its IV Extension Sets with BD Q-Syte Luer Access Device after BD notified the company that it had received complaints relating to the Q-Syte component of the device.

“Patient safety and the quality and safety of our products are Acacia’s first priorities,” Acacia said in the...
To view the full article, register now.